ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.726,41
-0,22%
S&P 500
5.315,02
0,13%
Dow Jones
39.871,68
0,16%
Euro vs US Dollar
1,08593
-0,01%
Bitcoin
70.322,48
-1,58%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Adagio Therapeutics Inc (ADGI)

  7. Adagio Therapeutics Inc (ADGI) News

ADGI

Adagio Therapeutics (ADGI)

Adagio Therapeutics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ADGI
DatumZeitQuelleÜberschriftSymbolFirma
29/06/202313h09Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADGIAdagio Therapeutics Inc
26/05/202300h44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADGIAdagio Therapeutics Inc
26/05/202300h43Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADGIAdagio Therapeutics Inc
26/05/202300h43Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADGIAdagio Therapeutics Inc
26/05/202300h38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADGIAdagio Therapeutics Inc
25/05/202322h23Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADGIAdagio Therapeutics Inc
12/04/202322h49Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADGIAdagio Therapeutics Inc
12/04/202322h47Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ADGIAdagio Therapeutics Inc
10/04/202322h20Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:ADGIAdagio Therapeutics Inc
10/04/202322h11Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ADGIAdagio Therapeutics Inc
10/04/202322h08Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ADGIAdagio Therapeutics Inc
31/03/202322h38Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:ADGIAdagio Therapeutics Inc
28/03/202322h55Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ADGIAdagio Therapeutics Inc
23/03/202321h31Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ADGIAdagio Therapeutics Inc
23/03/202321h13Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADGIAdagio Therapeutics Inc
06/03/202315h26Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADGIAdagio Therapeutics Inc
09/02/202317h48Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ADGIAdagio Therapeutics Inc
09/01/202313h12Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADGIAdagio Therapeutics Inc
19/12/202213h00GlobeNewswire Inc.Invivyd Presented Joint Industry Rationale on Potential Expedited Development Pathways for Monoclonal Antibodies at FDA-EMA WorkshopNASDAQ:ADGIAdagio Therapeutics Inc
16/12/202223h21Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADGIAdagio Therapeutics Inc
16/12/202223h17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADGIAdagio Therapeutics Inc
16/12/202223h11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADGIAdagio Therapeutics Inc
16/12/202223h11Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ADGIAdagio Therapeutics Inc
06/12/202222h29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADGIAdagio Therapeutics Inc
06/12/202222h01GlobeNewswire Inc.Invivyd Appoints Jeremy Gowler as Chief Operating and Commercial Officer, Promotes Pete Schmidt, M.D., to Chief Medical OfficerNASDAQ:ADGIAdagio Therapeutics Inc
29/11/202223h17Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:ADGIAdagio Therapeutics Inc
17/11/202213h11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADGIAdagio Therapeutics Inc
10/11/202222h32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ADGIAdagio Therapeutics Inc
10/11/202222h16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADGIAdagio Therapeutics Inc
04/11/202221h08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADGIAdagio Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:ADGI

Kürzlich von Ihnen besucht

TG
TUI1
Tui
NYSE
XOM
Exxon Mobil
CCOM
US30
US 30
DBI
MDAX
MDAX
NYSE
DIS
Walt Disney
USOTC
BASFY
BASF (QX)
NASDAQ
TSLA
Tesla
TG
MBG
MercedesBenz
TG
ALV
Allianz
CCOM
US500
US 500
AMEX
SPY
SPDR S&P 500
COIN
BTCUSD
Bitcoin
NYSE
MCD
McDonalds
TG
BAYN
Bayer
CCOM
US100
US Tech 100
NASDAQ
QQQ
Invesco QQQ Trust Series 1
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten